STUDIO-PUISTO
15.12.2022 11:44:40 CET | Business Wire | Press release
Solea’s concept of holistic healing answers to the demand of future travellers who look for deeper wellbeing beyond relaxation and meaningful experiences.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221215005489/en/
Solea Valley Healing resort in Cyprus offers travellers a holistic healing experience surrounded by nature. Image: Studio Puisto
“The increasingly hectic world makes people want to reconnect with nature and take care of their minds and bodies. Wellbeing elements are weaved throughout the entire stay at Solea. We offer our guests more than a vacation, an overall healing experience that will change their life”, says Sam-Erik Ruttmann, Studio Puisto’s Director of Global Hospitality Development.
The site is currently a beekeeping and honey farm and both continue to be an integral part of the location. Guests can study honey production and beekeeping or try apitherapy. Besides the healing spa, the resort has a restaurant, floating pools, sauna and extensive outdoor facilities.
The goal is to minimize impacts to the environment by integrating the resort with the surrounding nature.
"Nature is our inspiration and we want to set an example of how to incorporate it in the design. Beyond preserving, we aim to restore and enhance the diversity of the flora and fauna on site”, says Studio Puisto’s founding partner Willem van Bolderen.
The award-winning Finnish architecture office Studio Puisto specializes in hospitality design. Solea consists of 30 hotel rooms, 40 experiential lodges and 18 exclusive villas with a total capacity of 230 guests. Accommodation prototypes will be completed in early 2023 and the resort is expected to open in 2024.
Responsible travel is conscious travel
Sustainability is considered from materials, construction methods, drainage, lighting and energy solutions to the placement of the buildings.
“Our core value is to design sustainable projects that respect people and the environment. We believe that sustainability should cover the whole design process and the life cycle of the resort”, Van Bolderen continues.
Increasingly, conscious travellers decide their destination, accommodation and activities based on sustainability.
"People want authentic experiences they can enjoy without harming the environment. At Solea, guests can explore nature for example by studying permaculture or by planting a tree. We believe that holistic wellbeing comes from the opportunity to not only focus on oneself, but also to contribute to the wellbeing of the surrounding nature and community”, Ruttmann explains.
Studio Puisto is an architecture and interior design practice specializing in hospitality. The office’s projects are rooted in a Nordic mindset and range globally from a mountain resort in South Korea to a healing resort in Cyprus. Studio Puisto uses architecture as a vehicle to create new experiences and moments with a steadfast commitment of doing it sustainably.
Link
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221215005489/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission
KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press release
KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press release
The first SaaS SuperApp for startups and VCs capitalizes on a $25M round a from Nimbus Capital and a +15% stock surge, unveiling a v3/v4 roadmap that bridges public equity with digital asset liquidity. HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026061293689
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press release
Agricultural innovation leader to contribute with agronomic expertise in building accurate crop health, pest forecasting and heat stress models India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom